Acute liver failure in patients admitted to the intensive care unit—a Viennese retrospective single-center analysis
Wiener klinische Wochenschrift · 2025
DOI: 10.1007/s00508-025-02539-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Wiener klinische Wochenschrift, 2025. Verfasst von Patrick Haselwanter und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine III, Division of Gastroenterology and Hepatology, Intensive Care Unit 13H1, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Liver Failure, Acute, Intensive Care Units, Liver Transplantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Vienna.
Themen: Intensivpflege
Abstract (Originalsprache)
Background
Acute liver failure (ALF) is characterized by a rapid deterioration of liver function and a high mortality without transplantation depending on etiology and onset. Immediate transfer to a dedicated intensive care unit (ICU) and evaluation for high-urgency liver transplantation (HU-LTx) is recommended to maximize chances of survival. Data on ALF epidemiology are limited, particularly for Central Europe.
Methods
This retrospective single-center study included all ALF patients admitted to the ICU of the Department of Gastroenterology and Hepatology at the Vienna General Hospital between 2012 and 2024.
Results
Overall, 31 patients (median age of 44 [interquartile range, IQR 32–56] years, 20 [65%] female) were included. The primary causes of ALF were viral infections ( n = 8; 26%), autoimmune hepatitis ( n = 5; 16%), drug-induced liver injury (DILI; n = 3; 10%), and Wilson’s disease ( n = 4; 13%), while in 8 patients (26%) no cause was identified. Median length of ICU stay was 12 (IQR 4–21) days, with mean sequential organ failure assessment (SOFA) and simplified acute physiology score II (SAPS II) scores of 10.55 ± 4.56 and 40.97 ± 14.84. Overall ICU survival was 61% ( n = 19). Non-HU-LTx patients ( n = 18) had an ICU survival of 44%. HU-LTx was performed in 13 patients (42%), with 12 patients (92%) surviving 28 days. The 6‑month overall survival of HU-LTx patients was 85%.
Conclusion
The diverse causes of ALF in Central Europe include most commonly viral infections, autoimmune hepatitis, and DILI. HU-LTx was required and performed in almost half of patients and was associated with favorable survival rates, underscoring the importance of ICU management and early transfer to liver transplantation centers in the management of ALF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine III, Division of Gastroenterology and Hepatology, Intensive Care Unit 13H1, Medical University of Vienna, Vienna, Austria.
- Department of Medicine III, Division of Gastroenterology and Hepatology, Intensive Care Unit 13H1, Medical University of Vienna, Vienna, Austria. mathias.schneeweiss-gleixner@meduniwien.ac.at.
Förderung
- Medical University of Vienna
Zitieren
APA
Haselwanter, P., Fairfield, S., Riedl-Wewalka, M., Schmid, M., Stättermayer, A. F., Reiberger, T., Trauner, M., Zauner, C., & Schneeweiss-Gleixner, M. (2025). Acute liver failure in patients admitted to the intensive care unit—a Viennese retrospective single-center analysis. Wiener klinische Wochenschrift. https://doi.org/10.1007/s00508-025-02539-1
Vancouver
Haselwanter P, Fairfield S, Riedl-Wewalka M, Schmid M, Stättermayer AF, Reiberger T, et al. Acute liver failure in patients admitted to the intensive care unit—a Viennese retrospective single-center analysis. Wiener klinische Wochenschrift. 2025. doi:10.1007/s00508-025-02539-1
BibTeX
@article{Haselwanter2025,
author = {Haselwanter, Patrick and Fairfield, Seanna and Riedl-Wewalka, Marlene and Schmid, Monika and Stättermayer, Albert Friedrich and Reiberger, Thomas and Trauner, Michael and Zauner, Christian and Schneeweiss-Gleixner, Mathias},
title = {Acute liver failure in patients admitted to the intensive care unit—a Viennese retrospective single-center analysis},
journal = {Wiener klinische Wochenschrift},
year = {2025},
doi = {10.1007/s00508-025-02539-1}
}
EUVIMED